Immix Biopharma
Price & Volume
Stats
See more52W Range | $1.26-$3.79 |
Market Cap | $48.4M |
Shares Short | 335,267 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.84 |
News
See moreYahoo Finance • 14 days ago
Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis
Yahoo Finance • last year
Immix Biopharma to Present at the 2023 JMP Securities Hematology and Oncology Summit
About
CEO | Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D. |
CFO | Mr. Gabriel Morris B.A. |
Address | 11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |
